Impact BioMedical, Inc. (IBO)
3.84
+0.29
(+8.17%)
USD |
NYAM |
Oct 28, 13:53
Impact BioMedical Cash from Operations (Quarterly) : 0.47M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.47M |
| March 31, 2026 | -0.464M |
| December 31, 2025 | 0.099M |
| September 30, 2025 | -0.613M |
| June 30, 2025 | -0.694M |
| March 31, 2025 | -0.682M |
| December 31, 2024 | -1.256M |
| September 30, 2024 | -1.285M |
| June 30, 2024 | -0.896M |
| March 31, 2024 | -0.482M |
| December 31, 2023 | -0.433M |
| September 30, 2023 | -0.671M |
| Date | Value |
|---|---|
| June 30, 2023 | -0.733M |
| March 31, 2023 | -1.014M |
| December 31, 2022 | -0.363M |
| September 30, 2022 | -0.802M |
| June 30, 2022 | -0.544M |
| March 31, 2022 | -0.533M |
| December 31, 2021 | -0.79M |
| September 30, 2021 | -0.4927M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | -0.4272M |
| September 30, 2020 | -0.1182M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| LENZ Therapeutics, Inc. | -38.71M |
| Enveric Biosciences, Inc. | -2.444M |
| ANI Pharmaceuticals, Inc. | 56.67M |
| Corcept Therapeutics, Inc. | 33.54M |
| Veru, Inc. | -5.467M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 0.002M |
| Cash from Financing (Quarterly) | -0.482M |
| Free Cash Flow | -0.508M |
| Free Cash Flow Per Share (Quarterly) | 0.055 |
| Free Cash Flow to Equity (Quarterly) | 0.47M |
| Free Cash Flow to Firm (Quarterly) | 0.47M |
| Free Cash Flow Yield | -2.01% |